Health-related Quality of Life in Adults After Veno-arterial Extra-Corporeal Membrane Oxygenation
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Evaluation of health-related quality of life after veino-arterial ECMO
Study Overview
Brief Summary
Extracorporeal Membrane Oxygenation (ECMO) is a salvage therapy used in patients with refractory cardiogenic shock. This rescue technique is associated to a high mortality rate and to many complications that can impact the quality of life of the survivors. The aim of this study is to evaluate the Health-related quality of life in adults after veino-arterial Extra-Corporeal Membrane Oxygenation. The quality of life will be evaluated thanks to several methods : the Short Form 36, the EQ 5D 5L and the return to work status.
Then, the investigators will analyze by subgroup the quality of life according to the cardiogenic shock etiology and try to determine the risk factors of an altered quality of life. The investigators will also evaluate current comorbidities of the patient thanks to the Groll Index.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 95 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults >18 years
- •Veno-arterial ECMO between April 2008 and December 2019 in NHC surgical intensive care of Strasbourg
- •Affiliated to the French social security system
Exclusion Criteria
- •Patients under guardianship or with legal protection
Outcomes
Primary Outcomes
Evaluation of health-related quality of life after veino-arterial ECMO
Time Frame: The quality of life will be evaluated from 1 to 12 years after the ECMO
EQ 5D 5L ( description of mobility, personal autonomy, routine activities, pain and discomfort, anxiety and depression and an analog visual scale)
Secondary Outcomes
- Analysis by subgroup according to the cardiogenic shock etiology(The quality of life will be evaluated from 1 to 12 years after the ECMO)
- Research of risk factors of an altered quality of life(The quality of life will be evaluated from 1 to 12 years after the ECMO)
- Evaluation of the current comorbidities thanks to Groll index(The quality of life will be evaluated from 1 to 12 years after the ECMO)